Equivalent of Form PTO/SB/08a/b (07-09)
`Approvedfor use through 05/31/2024. OMB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respondto a collection of information unless it contains a valid OMB control number.
`Complete if Known|CompleteifKnown
`Substitute for form 1449/PTO
`
`4902.0110003
`
`INFORMATION DISCLOSURE
`STATEMENTBY APPLICANT
`(Use as many sheets as necessary)
`
`First Named Inventor
`
`Attommey Docket Number_[
`
`Rhett Mead SCHIFFMAN
`1629
`To Be Assigned
`
`U.S. PATENT DOCUMENTS
`RelevantPassagesorRelevant
`Publication Date
`Document Number
`Cite
`Examiner
`NameofPatentee or
`DD.
`-
`1
`“xa
`;
`:
`” _ |
`
`
`
`
`initials* Figures Appear No. Number-Kind Code 2 (if known) MM-DD-YYYY Applicant of Cited Document
`
`
`S-20030036535-Al|02-20-2003 NOLAN;G.
`alenlnwiry
`7US-20110152274-Al_|06-23-2011[KAUFMAN
`oe
`
`"US-20160250225-AT|09-01-2016CHANG:C.etahSiS
`a\c
`Cc NM&
`aND On
`
`a
`
`KAUFMAN:H.
`09-19-2013
`S-20130245030-Al
`S-20150065511-Al|03-05-2015
`
`an FicjalalePin|niniwmalel;eina
`
`S-20100173833-Al
`S-20140113946-Al|04-24-2014|ABAD;J. Po
`S-20090156606-Al|06-18-2009|SHARMA:A. Po
`io MN — —,S-20120329805-Al
` algN!NMleWw]de
`alc
`S-8299079-B2
`S-8455494-B2
`
`10-30-2012
`06-04-2013
`
`KAUFMAN:H.
`
`CG TN — &
`gND _ Nn
`S-20220175734-Al|06-09-2022 SAMBURSKY;RP., etal.
`
`
`Al|07-06-2023 SAMBURSKY;R_P., et al.
`
`S-20180078500-Al
`
`Cc
`
`|
`
`Foreign Patent Document
`
`FOREIGN PATENT DOCUMENTS
`i
`nati
`
`
`
`Examiner Cite[|Foinraen:Document|Publication NameofPatentee or Be
`
`
`initials*
`No.!
`Country Code3-Number+Kind
`MM-DD-YYYY
`Applicant of Cited Document
`Code(if known)
`WO-2016172712-A2|10-27-2016|SYDNEXUS, INC. [US]
`
`WO-2020252057-Al|12-17-2020|VISUS THERAPEUTICS, INC. [US]
`
`
`CA-2747095-C 02-18-2020|SHARMA ANANT[GB] fT
`
`[Pres[wo-2020252061-a1_|12-17-2020|VISUSTHERAPEUTICS,INC[US||||
`
`FP5|WO-2016205068-Al 12-22-2016|PRESBYOPIA THERAPIES LLC [US]
`
`a
` a S-20230210821-
`
`
`
`
`
`
`Fire[Wosoiinaistat-[osttaniy[eyowexisNees)
`
`[FFP[w0-2017160548-a1_|09-21-2017|PRESBYOPIATHERAPIESLLC[us|||_|
`
`
`-Pres[wo-2020219707-al|10-29-2020|ALLERGAN.INC[US|———SSS*dSSidSd
`WO-2014015183-Al_| 01-23-2014|LUIS FELIPE VEJARANO RESTREPO [CO]|[|
`
`FP10|WO-2021021644-Al|02-04-2021|ALLERGAN SALES LLC [US] ||
`FP11|WO-2021021646-Al|02-04-2021|ALLERGAN INC [US]
`
`Examiner Signature| ate Considered |
`
`*EXAMINER:Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance
`and not considered. Include copy of this form with next communication to applicant.
`| Applicant’s unique citation designation number (optional). * See
`Kinds Codes of USPTO Patent Documents at www.uspto.gov or MPEP 901.04. ? Enter Office that issued the document, by the two-letter code (WIPO
`Standard ST.3). + For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial number of the patent
`document. ° Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. ° Applicant is to place a
`check mark here if English language Translationis attached.
`
`

`

`Equivalent of Form PTO/SB/08a/b (07-09)
`Approvedfor use through 05/31/2024. OMB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respondto a collection of information unless it contains a valid OMB control number.
`Complete if Known|CompleteifKnown
`Substitute for form 1449/PTO
`
`To Be Assigned Attorney Docket Number_|4902.0110003
`
`INFORMATION DISCLOSURE
`STATEMENTBY APPLICANT
`(Use as many sheets as necessary)
`
`First Named Inventor
`
`Rhett Mead SCHIFFMAN
`1629
`
`
`
` Include nameofthe author (in CAPITAL LETTERS), title of the article (when appropriate), title of the item (book,
`
`NON PATENT LITERATURE DOCUMENTS
`
`Examiner
`magazine, journal, serial, symposium,catalog, etc.), date, page(s), volume-issue number(s), publisher, city and/or country
`T?
`Initials®|Cite No.’
`where published
`
`International Search Report and Written Opinion for International Application No.
`PCT/US2020/037042, USPTO, mailed on October 16, 2020, 20 pages
`
`ABDELKADER,A., "Improved Presbyopic Vision With Miotics," Eye Contact Lens
`41(5):323- 7, Lippincott Williams and Wilkins Ltd., United States (September 2015)
`
`ABDELKADER,A., "Influence of Different Concentrations of Carbachol Dropson the
`Outcome of Presbyopia Treatment-A Randomized Study," International Journal of
`Ophthalmic Research 5(1):317-320, ACT Publishing Group Limited, United Kingdom
`(2019)
`
`ABDELKADER,A., et al., "Clinical outcomes of combined versus separate carbachol and
`brimonidine drops in correcting presbyopia," Eye Vis (Lond) 3:31, BioMed Central, United
`Kingdom (December 2016)
`
`International Search Report and Written Opinion for International Application No.
`PCT/US2020/037046, USPTO, mailed on October 26, 2020, 14 pages
`
`ABDELKADER,A. "A Novel Pharmacological Treatment of Pseudophakic Presbyopia,"
`International Journal of Ophthalmic Research 4(2): 291-294, ACT Publishing Group Limited,
`United Kingdom (2018)
`
`International Search Report and Written Opinion for International Application No.
`PCT/US2021/057720, Commissioner for Patents, United States, mailed on February 1, 2022,
`16 pages.
`
`21028362.1
`
`Examiner Signature| ate Considered |
`
`*EXAMINER:Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance
`and not considered. Include copy of this form with next communication to applicant.
`| Applicant’s unique citation designation number (optional). * See
`Kinds Codes of USPTO Patent Documents at www.uspto.gov or MPEP 901.04. ? Enter Office that issued the document, by the two-letter code (WIPO
`Standard ST.3). + For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial number of the patent
`document. ° Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. ° Applicant is to place a
`check mark here if English language Translationis attached.
`
`